SQ 33600: structure given in first source
ID Source | ID |
---|---|
PubMed CID | 131696 |
SCHEMBL ID | 5597751 |
MeSH ID | M0181929 |
Synonym |
---|
unii-3kf8m81w01 |
133983-25-2 |
butanoic acid, 4-(((1-(4-fluorophenyl)-3-(1-methylethyl)-1h-indol-2-yl)ethynyl)hydroxyphosphinyl)-3-hydroxy-, disodium salt, (s)- |
3kf8m81w01 , |
sq 33,600 |
sq 33600 |
SCHEMBL5597751 |
sq-33600 |
butanoic acid, 4-((2-(1-(4-fluorophenyl)-3-(1-methylethyl)-1h-indol-2-yl)ethynyl)hydroxyphosphinyl)-3-hydroxy-, sodium salt (1:2), (3s)- |
disodium 4-({[1-(4-fluorophenyl)-3-(propan-2-yl)-1h-indol-2-yl]ethynyl}phosphinato)-3-hydroxybutanoate |
DTXSID00928371 |
disodium;(3s)-4-[2-[1-(4-fluorophenyl)-3-propan-2-ylindol-2-yl]ethynyl-oxidophosphoryl]-3-hydroxybutanoate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |